March 2017 Current Affairs
28 MAR
NEWS
27 MAR
NEWS
25 MAR
NEWS
24 MAR
NEWS
23 MAR
NEWS
22 MAR
NEWS

February 2017 Current Affairs
28 FEB
NEWS
27 FEB
NEWS
25 FEB
NEWS
24 FEB
NEWS
23 FEB
NEWS
22 FEB
NEWS

January 2017 Current Affairs
31 JAN
NEWS
30 JAN
NEWS
28 JAN
NEWS
27 JAN
NEWS
25 JAN
NEWS
24 JAN
NEWS

December 2016 Current Affairs
31 DEC
NEWS
30 DEC
NEWS
29 DEC
NEWS
28 DEC
NEWS
27 DEC
NEWS
26 DEC
NEWS

November 2016 Current Affairs
30 NOV
NEWS
29 NOV
NEWS
28 NOV
NEWS
26 NOV
NEWS
25 NOV
NEWS
24 NOV
NEWS

Indian Pharma companies rank 19th in Biopharmaceutical Competitiveness & Investment (BCI) Survey

Indian Pharma companies rank 19th in Biopharmaceutical Competitiveness & Investment (BCI) Survey
11 October 2016 Current Affairs: Indian pharmaceutical companies have ranked low at 19th position with an overall score of 59 out of 100 among in the Biopharmaceutical Competitiveness & Investment (BCI) Survey. 

The survey of 28 countries was commissioned by the Pharmaceutical Research and Manufacturers of America and executed by the Pugatch Consilium. It was third edition of survey.

Five metrics were used to determine rankings of countries. They are (i) scientific capabilities and infrastructure; (ii) clinical research conditions and framework; (iii) regulatory system; (iv) market access and financing; and (v) effective intellectual property protections. It had looked at biomedical innovation and its influencers, like intellectual property protection for investments in the pharmaceutical sector. It had categorized countries into two groups viz. mature markets like UK US, and Germany, and newcomers like China, India and Brazil.

Highlights of Survey :  Mature markets provide advanced intellectual property protection, highly streamlined regulatory framework and favourable tax conditions with some exceptions. India, along with China, Argentina, Colombia, Russia, Turkey and Brazil based on their overall score were labelled as trailing markets. 

Singapore which has placed in the newcomers category with a score of 85 is only a point behind the US, which is a mature market. India scores low on almost all metrics except in the clinical research conditions and framework and scientific capabilities and infrastructure. India’s IP regime, including Section 3(d) of IP Act requiring biopharmaceutical inventions to show ‘enhanced efficacy’, continues to affect its investment environment.


March 2017 Current affairs
28 MAR
NEWS
27 MAR
NEWS
25 MAR
NEWS
24 MAR
NEWS
23 MAR
NEWS
22 MAR
NEWS

February 2017 Current affairs
28 FEB
NEWS
27 FEB
NEWS
25 FEB
NEWS
24 FEB
NEWS
23 FEB
NEWS
22 FEB
NEWS




January 2017 Current affairs
31 JAN
NEWS
30 JAN
NEWS
28 JAN
NEWS
27 JAN
NEWS
25 JAN
NEWS
24 JAN
NEWS

December 2016 Current affairs
31 DEC
NEWS
30 DEC
NEWS
29 DEC
NEWS
28 DEC
NEWS
27 DEC
NEWS
26 DEC
NEWS

November 2016 Current affairs
30 NOV
NEWS
29 NOV
NEWS
28 NOV
NEWS
26 NOV
NEWS
25 NOV
NEWS
24 NOV
NEWS



FreshersLive - No.1 Job site in India. Fresherslive Current Affairs 2017 section offers informative quiz questions with answers regarding latest current affairs today for all sorts of competitive exams like UPSC, TNPSC , IFS, IAS, IPS, railway exams (RRB) and banking exams like IPBS PO, IPBS clerk, Federal Bank PO, ICICI, SBI, RBI legal officer & Grade officer posts and much more. Register with us to get latest Current Affairs Updates. Also get latest Current Affairs news and quiz Updates for free alerts daily through E-mail

Get Daily Current Affairs to your Email

You can Unsubscribe us at any time.

Get Daily Current Affairs to your Email

You can Unsubscribe us at any time.